CV Sciences (0HRT) Ratios
CV Sciences Ratios
GB:0HRT's free cash flow for Q2 2026 was $13.00K. For the 2026 fiscal year, GB:0HRT's free cash flow was decreased by $-7.00K and operating cash flow was $20.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.03 | 1.02 | 1.30 | 0.84 | 0.98 |
| Quick Ratio | 0.21 | 0.22 | 0.37 | 0.34 | 0.38 |
| Cash Ratio | 0.06 | 0.07 | 0.22 | 0.05 | 0.10 |
| Solvency Ratio | -0.10 | -0.34 | 0.14 | -0.53 | -0.97 |
| Operating Cash Flow Ratio | -0.08 | -0.14 | 0.37 | -0.14 | -0.52 |
| Short-Term Operating Cash Flow Coverage | -0.27 | -1.27 | 8.87 | -1.54 | -8.12 |
| Net Current Asset Value | $ -361.00K | $ 111.00K | $ -15.51M | $ -2.38M | $ -337.00K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.10 | 0.02 | 0.12 | 0.05 |
| Debt-to-Equity Ratio | 1.10 | 0.43 | 0.15 | -1.97 | 0.26 |
| Debt-to-Capital Ratio | 0.52 | 0.30 | 0.13 | 2.03 | 0.21 |
| Long-Term Debt-to-Capital Ratio | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 4.74 | 4.42 | 9.08 | -16.39 | 5.10 |
| Debt Service Coverage Ratio | -0.28 | -2.08 | 15.17 | -2.03 | -13.10 |
| Interest Coverage Ratio | -1.92 | -10.33 | 0.00 | -4.44 | -131.76 |
| Debt to Market Cap | 0.17 | 0.11 | 0.05 | 0.27 | 0.07 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.00 | 0.02 | 0.01 |
| Net Debt to EBITDA | -2.37 | -0.18 | -0.23 | -0.16 | 0.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 48.97% | 45.64% | 44.27% | 34.25% | 42.98% |
| EBIT Margin | -7.19% | -13.94% | 22.56% | -41.47% | -77.32% |
| EBITDA Margin | -4.08% | -11.82% | 24.03% | -34.92% | -69.82% |
| Operating Profit Margin | -7.19% | -13.94% | 20.99% | -42.25% | -92.01% |
| Pretax Profit Margin | -6.88% | -15.29% | 19.35% | -50.98% | -78.02% |
| Net Profit Margin | -6.95% | -15.24% | 19.38% | -50.69% | -77.58% |
| Continuous Operations Profit Margin | -6.95% | -15.24% | 19.38% | -50.69% | -77.58% |
| Net Income Per EBT | 100.95% | 99.67% | 100.19% | 99.43% | 99.44% |
| EBT Per EBIT | 95.67% | 109.68% | 92.14% | 120.65% | 84.79% |
| Return on Assets (ROA) | -13.76% | -30.20% | 11.77% | -64.49% | -86.10% |
| Return on Equity (ROE) | -65.26% | -133.37% | 106.85% | 1057.14% | -439.01% |
| Return on Capital Employed (ROCE) | -50.56% | -120.46% | 16.61% | 1184.60% | -511.68% |
| Return on Invested Capital (ROIC) | -28.58% | -84.67% | 16.30% | -893.44% | -405.20% |
| Return on Tangible Assets | -16.32% | -34.88% | 11.96% | -65.79% | -93.81% |
| Earnings Yield | -8.47% | -40.34% | 57.00% | -183.66% | -120.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 34.30 | 30.09 | 37.13 | 21.16 | 9.82 |
| Payables Turnover | 6.74 | 4.43 | 3.86 | 4.67 | 4.36 |
| Inventory Turnover | 1.72 | 1.74 | 1.58 | 1.62 | 1.33 |
| Fixed Asset Turnover | 19.96 | 31.86 | 29.31 | 19.06 | 11.68 |
| Asset Turnover | 1.98 | 1.98 | 0.61 | 1.27 | 1.11 |
| Working Capital Turnover Ratio | 103.29 | 16.05 | -88.66 | -13.18 | 17.80 |
| Cash Conversion Cycle | 168.48 | 139.20 | 146.76 | 163.84 | 228.73 |
| Days of Sales Outstanding | 10.64 | 12.13 | 9.83 | 17.25 | 37.16 |
| Days of Inventory Outstanding | 211.99 | 209.37 | 231.42 | 224.82 | 275.35 |
| Days of Payables Outstanding | 54.15 | 82.30 | 94.49 | 78.24 | 83.78 |
| Operating Cycle | 222.63 | 221.50 | 241.25 | 242.08 | 312.51 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | 0.01 | -0.01 | -0.07 |
| Free Cash Flow Per Share | -0.00 | -0.01 | 0.01 | -0.01 | -0.07 |
| Dividend Paid and CapEx Coverage Ratio | -3.73 | -47.83 | 0.00 | 0.00 | -213.86 |
| Capital Expenditure Coverage Ratio | -3.73 | -47.83 | 0.00 | 0.00 | -213.86 |
| Operating Cash Flow Coverage Ratio | -0.25 | -1.11 | 5.10 | -1.23 | -8.12 |
| Operating Cash Flow to Sales Ratio | -0.03 | -0.05 | 0.14 | -0.12 | -0.37 |
| Free Cash Flow Yield | -4.56% | -14.81% | 41.40% | -42.15% | -58.12% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -11.81 | -2.48 | 1.75 | -0.54 | -0.83 |
| Price-to-Sales (P/S) Ratio | 0.82 | 0.38 | 0.34 | 0.28 | 0.65 |
| Price-to-Book (P/B) Ratio | 7.71 | 3.31 | 1.87 | -5.76 | 3.65 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -21.93 | -6.75 | 2.42 | -2.37 | -1.72 |
| Price-to-Operating Cash Flow Ratio | -27.80 | -6.89 | 2.42 | -2.37 | -1.73 |
| Price-to-Earnings Growth (PEG) Ratio | 0.19 | 0.01 | -0.01 | 0.01 | 0.02 |
| Enterprise Value Multiple | -22.50 | -3.37 | 1.19 | -0.95 | -0.89 |
| Enterprise Value | 12.64M | 6.26M | 4.57M | 5.39M | 12.49M |
| EV to EBITDA | -22.50 | -3.37 | 1.19 | -0.95 | -0.89 |
| EV to Sales | 0.92 | 0.40 | 0.29 | 0.33 | 0.62 |
| EV to Free Cash Flow | -24.51 | -7.12 | 2.03 | -2.86 | -1.66 |
| EV to Operating Cash Flow | -31.07 | -7.27 | 2.03 | -2.86 | -1.67 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.02 | -0.01 | 0.02 |
| Shareholders’ Equity Per Share | 0.01 | 0.01 | 0.02 | -0.01 | 0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.00 | -0.00 | 0.01 | 0.01 |
| Revenue Per Share | 0.07 | 0.09 | 0.10 | 0.12 | 0.19 |
| Net Income Per Share | -0.01 | -0.01 | 0.02 | -0.06 | -0.14 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 0.99 | 0.99 |
| Interest Burden | 0.96 | 1.10 | 0.86 | 1.23 | 1.01 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.06 |
| SG&A to Revenue | 0.55 | 0.59 | 0.41 | 0.24 | 0.69 |
| Stock-Based Compensation to Revenue | 0.04 | 0.02 | 0.01 | 0.06 | 0.16 |
| Income Quality | 0.42 | 0.36 | 0.73 | 0.23 | 0.48 |
Currency in USD